Oral racemic ketamine for common clinical contexts in patients with major depressive disorder: An important intervention that treatment guidelines may never include.
作者信息
Andrade Chittaranjan
机构信息
Department of Clinical Psychopharmacology and Neurotoxicology, National Institute of Mental Health and Neurosciences, Bangalore, India.
出版信息
Bipolar Disord. 2022 Mar;24(2):113-114. doi: 10.1111/bdi.13155. Epub 2021 Nov 23.
PMID:34816542
Abstract
摘要
相似文献
1
Oral racemic ketamine for common clinical contexts in patients with major depressive disorder: An important intervention that treatment guidelines may never include.
Bipolar Disord. 2022 Mar;24(2):113-114. doi: 10.1111/bdi.13155. Epub 2021 Nov 23.
2
Ketamine as an alternative treatment for treatment-resistant depression.
Perspect Psychiatr Care. 2013 Jan;49(1):2-4. doi: 10.1111/ppc.12006. Epub 2012 Dec 30.
3
KETAMINE FOR TREATMENT-RESISTANT UNIPOLAR AND BIPOLAR MAJOR DEPRESSION: CRITICAL REVIEW AND IMPLICATIONS FOR CLINICAL PRACTICE.
Depress Anxiety. 2016 Aug;33(8):698-710. doi: 10.1002/da.22505. Epub 2016 Apr 6.
4
Ketamine administration in depressive disorders: a systematic review and meta-analysis.
Psychopharmacology (Berl). 2014 Sep;231(18):3663-76. doi: 10.1007/s00213-014-3664-5. Epub 2014 Jul 20.
5
Ketamine's effectiveness in unipolar versus bipolar depression.
Psychopharmacology (Berl). 2014 Nov;231(22):4417-8. doi: 10.1007/s00213-014-3773-1. Epub 2014 Oct 15.
6
Predictors of Response to Ketamine in Treatment Resistant Major Depressive Disorder and Bipolar Disorder.
Int J Environ Res Public Health. 2018 Apr 17;15(4):771. doi: 10.3390/ijerph15040771.
7
A comment on Fond and colleagues' systematic review and meta-analysis of ketamine in the treatment of depressive disorders (Psychopharmacology 2014; Jul 20 [Epub ahead of print]).
Psychopharmacology (Berl). 2014 Oct;231(19):3907-8. doi: 10.1007/s00213-014-3731-y. Epub 2014 Sep 2.
8
Repeated dosing with oral racemic ketamine as a successful rescue intervention for coping with life events in recurrent major depressive disorder.
Asian J Psychiatr. 2024 Apr;94:103973. doi: 10.1016/j.ajp.2024.103973. Epub 2024 Feb 21.
9
A word to the wise about ketamine.
Am J Psychiatry. 2014 Mar;171(3):262-4. doi: 10.1176/appi.ajp.2014.13101434.
10
Continuation phase intravenous ketamine in adults with treatment-resistant depression.
J Affect Disord. 2016 Dec;206:300-304. doi: 10.1016/j.jad.2016.09.008. Epub 2016 Sep 12.
引用本文的文献
1
Oral esketamine for patients with severe treatment-resistant depression: Effectiveness, safety, and tolerability of a six-week open-label treatment program.
J Psychopharmacol. 2025 Jun;39(6):559-570. doi: 10.1177/02698811251332831. Epub 2025 Apr 25.
2
Therapeutic Compatibility of Orally Administered Racemic Ketamine with Modafinil, a CYP3A4 Enzyme Inducer, in Treatment-Refractory Major Depressive Disorder.
Indian J Psychol Med. 2023 Nov;45(6):651-653. doi: 10.1177/02537176231160264. Epub 2023 Mar 29.
Zotero 插件